Received: 11 December 2018
Accepted: 17 April 2019
First Online: 6 May 2019
Ethics approval and consent to participate
: The present study was approved by Nizam’s Institute of Medical Sciences -Institutional Ethics Committee (NIEC), IRB/NIMS/011(a) 2012.Written informed consent was taken from all the subjects prior to participation in the study.
: Not Applicable.
: Authors declare no competing interests. We acknowledge Natreon, Inc., USA, for providing study medications and kits for biomarkers.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.